HTLV-1 associated myelopathy
Apr. 11, 2022
Professor of Neurology
University of Chicago
Editorial Board Member since 2000: Neuroimmunology
Clinical Interests: Neuromyelitis optica, multiple sclerosis, tetanus, neuroimmunology
Dr. Reder of the University of Chicago received honorariums from Bayer, Biogen Idec, Genentech, Genzyme, Novartis, Mallinckrodt, and Serono for service on advisory boards and as a consultant, stock options from NKMax America for advisory work, and translational research from BMS for service as principle investigator.